1 unchanged sentence
Exhibit Number
−Removed: Amendment to Convertible Promissory Note, dated March 30, 2023, by and between NRx Pharmaceuticals, Inc.
+Added: Amendment to Convertible Promissory Note, dated June 30, 2023, by and between NRx Pharmaceuticals, Inc.
and Streetervillle Capital LLC.
4 unchanged sentences
Interactive data files pursuant to Rule 405 of Regulation S-T formatted in Inline XBRL:
−Removed: (i) Condensed Consolidated Balance Sheets as of March 31, 2023 (Unaudited) and December 31, 2022;
−Removed: (ii) Unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022 ;
−Removed: (iii) Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) for the three months ended March 31, 2023 and 2022;
−Removed: (iv) Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022;
+Added: (i) Condensed Consolidated Balance Sheets as of June 30, 2023 (Unaudited) and December 31, 2022;
+Added: (ii) Unaudited Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2023 and 2022 ;
+Added: (iii) Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) for the six months ended June 30, 2023 and 2022;
+Added: (iv) Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2023 and 2022;
and (v) Notes to Unaudited Financial Statements.
6 unchanged sentences
NRX PHARMACEUTICALS, INC.
+Added: August 14, 2023
/s/ Seth Van Voorhees
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.